Relay Therapeutics Stock (NASDAQ: RLAY) stock price, news, charts, stock research, profile.
Open | $6.160 |
Close | $6.155 |
Volume / Avg. | 1.386M / 1.192M |
Day Range | 5.820 - 6.210 |
52 Wk Range | 5.700 - 13.320 |
Market Cap | $814.521M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 10.85% |
Days to Cover | 8.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Relay Therapeutics (NASDAQ: RLAY) through any online brokerage.
Other companies in Relay Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for Relay Therapeutics (NASDAQ: RLAY) was reported by Stifel on Thursday, February 22, 2024. The analyst firm set a price target for 30.00 expecting RLAY to rise to within 12 months (a possible 387.41% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $6.155 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Relay Therapeutics.
Relay Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Relay Therapeutics.
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.